Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11173104 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL19742962 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL9117801 | 0.95 | ALDH1A1 (0.36) | ALDH1A1TSHRTDP1 | |
| SCHEMBL43809 | 0.95 | — | — | |
| Water SCHEMBL23801211 | 0.91 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL4952021 | 0.89 | ALDH1A1 (0.31) | ALDH1A1TSHRTDP1 | |
| SCHEMBL389363 | 0.84 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL377335 | 0.84 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| Ethyl Chloride SCHEMBL4775177 | 0.84 | TSHR (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL11300184 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12343351-B2 | Pulmonary function treatment | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-07-01 | — | — | US | claimed |
| EP-3914286-B1 | METHODS OF MITIGATING TOXIC EFFECTS OF VESICANTS AND CAUSTIC GAS | JANSSEN PHARMACEUTICA NV (BE) | 2025-05-07 | — | — | EP | claimed |
| US-20230302018-A1 | PULMONARY FUNCTION TREATMENT | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2023-09-28 | — | — | US | claimed |
| US-11717532-B2 | Methods and compositions for treating wounds utilizing chitosan compounds | SYNEDGEN, INC. (US) | 2023-08-08 | — | — | US | claimed |
| US-11273203-B2 | Methods of mitigating toxic effects of vesicants and caustic gas | JANSSEN PHARMACEUTICA NV (BE) | 2022-03-15 | — | — | US | claimed |
| US-11071795-B2 | Indicating devices based on etching of metals | JP LABORATORIES INC. (US) | 2021-07-27 | — | — | US | claimed |
| US-20180024011-A1 | Indicating Devices Based on Etching of Metals | JP LABORATORIES INC. | 2018-01-25 | — | — | US | claimed |
| US-8557730-B2 | Composition and process for making the composition | MOLYCORP MINERALS, LLC (US) | 2013-10-15 | — | — | US | claimed |
| US-8343437-B2 | Monitoring system based on etching of metals | JP LABORATORIES, INC. (US) | 2013-01-01 | — | — | US | claimed |
| US-8252087-B2 | Process and apparatus for treating a gas containing a contaminant | MOLYCORP MINERALS, LLC (US) | 2012-08-28 | — | — | US | claimed |
| US-20100284905-A1 | Methods and Agents for Inhibiting Tumor Growth by Targeting the SSDNA Replication Intermediate of Tumor Stem Cells | Massachusetts Institute of Tehnology | 2010-11-11 | — | — | US | claimed |
| US-20100168498-A1 | APPARATUS AND PROCESS FOR TREATING AN AQUEOUS SOLUTION CONTAINING CHEMICAL CONTAMINANTS | MOLYCORP MINERALS, LLC (US) | 2010-07-01 | — | — | US | claimed |
| EP-2171448-A2 | METHODS AND AGENTS FOR INHIBITING TUMOR GROWTH BY TARGETING THE SSDNA REPLICATION INTERMEDIATE OF TUMOR STEM CELLS | Massachusetts Institute of Technology (US) | 2010-04-07 | — | — | EP | claimed |
| US-20090301382-A1 | Monitoring System Based on Etching of Metals | JP LABORATORIES, INC | 2009-12-10 | — | — | US | claimed |
| WO-2008156629-A2 | METHODS AND AGENTS FOR INHIBITING TUMOR GROWTH BY TARGETING THE SSDNA REPLICATION INTERMEDIATE OF TUMOR STEM CELLS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-12-24 | — | — | WO | claimed |
| US-20070114121-A1 | Signal activated decontaminating coating | CROSSLINK POLYMER RESEARCH (US) | 2007-05-24 | — | — | US | claimed |
| EP-1166825-A1 | Formulations for neutralization of chemical and biological toxants | Sandia Corporation (US) | 2002-01-02 | — | — | EP | claimed |
| EP-0783682-B1 | DETECTION OF SULPHUR CONTAINING COMPOUNDS | SECR DEFENCE (GB) | 1999-07-21 | — | — | EP | claimed |
| EP-4743121-A1 | METAL SCAVENGER | PharmaLundensis AB (SE) | 2026-05-20 | — | — | EP | disclosed |
| US-4083692-A | Detection and estimation of microquantities of alkylating agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1978-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11273203-B2 | Methods of mitigating toxic effects of vesicants and caustic gas | CXCL8, GPR88, TPSG1 | ALDH1A1 802/4885TSHR 1286/4885TDP1 1658/4885 |
| US-11717532-B2 | Methods and compositions for treating wounds utilizing chitosan compounds | CHIA, MMP8, CHIT1 | ALDH1A1 2248/4885TSHR 4714/4885TDP1 3796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.